Neurokinin3 receptor modulation of the behavioral and neurochemical effects of cocaine in rats and monkeys

被引:0
|
作者
de Souza Silva, Maria A. [1 ]
Jocham, Gerhard [2 ]
Barros, Marilia [3 ]
Tomaz, Carlos [3 ,4 ]
Mueller, Christian P. [1 ]
机构
[1] Univ Dusseldorf, Inst Physiol Psychol 1, D-40225 Dusseldorf, Germany
[2] Max Planck Inst Neurol Res, Cologne, Germany
[3] Univ Brasilia, Sch Hlth Sci, Dept Pharmaceut Sci, BR-70910900 Brasilia, DF, Brazil
[4] Univ Brasilia, Inst Biol, Ctr Primate, Brasilia, DF, Brazil
关键词
NK receptors; cocaine; dopamine; nucleus accumbens; reinforcement; psychostimulant activation; place preference; marmosets;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurokinin(3) (NK3) receptors and their endogenous ligands (e.g. the neuropeptide substance P and its C-terminal fragment) have been implicated in psychomotor activity and reinforcement mechanisms. We review here recent findings on the involvement of NK3 receptors in the behavioral and neurochemical effects of cocaine. Although NK3 receptors can modulate dopamine (DA) activity in the brain, recent results suggest that this modulation does not occur during spontaneous behavioral activity. However, NK3 receptors play a role in the regulation of cocaine-induced DA responses in the nucleus accumbens core and shell subregions. NK3 receptor agonism as well as antagonism potentiate cocaine's effects on nucleus accumbens DA subregions specifically, and modulate the acute behavioral effects of cocaine in rats and non-human primates (Callithrix penicillata). However, conditioned place preference studies in rats have, so far, failed to provide evidence for an involvement of NK3 receptors in the reinforcing effects of cocaine.
引用
收藏
页码:101 / 111
页数:11
相关论文
共 50 条
  • [21] Neurokinin3 receptor antagonism attenuates cocaine's behavioural activating effects yet potentiates its dopamine-enhancing action in the nucleus accumbens core
    Jocham, Gerhard
    Lezoch, Katharina
    Mueller, Christian P.
    Kart-Teke, Emriye
    Huston, Joseph P.
    de Souza Silva, M. Angelica
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2006, 24 (06) : 1721 - 1732
  • [22] Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys
    Czoty, PW
    Ginsburg, BC
    Howell, LL
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03): : 831 - 837
  • [23] BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF HYDERGINE IN RATS
    COPELAND, RL
    BHATTACHARYYA, AK
    AULAKH, CS
    PRADHAN, SN
    [J]. ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1981, 252 (01): : 113 - 123
  • [24] BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF ARECOLINE IN RATS
    MHATRE, RM
    DUTTA, SN
    PRADHAN, SN
    [J]. FEDERATION PROCEEDINGS, 1970, 29 (02) : A749 - +
  • [25] COMPARATIVE BEHAVIORAL PROFILE OF COCAINE AND NORCOCAINE IN RATS AND MONKEYS
    BEDFORD, JA
    BORNE, RF
    WILSON, MC
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1980, 13 (01) : 69 - 75
  • [26] Effects of muscarinic M1 receptor stimulation on reinforcing and neurochemical effects of cocaine in rats
    Weikop, Pia
    Jensen, Kathrine L.
    Thomsen, Morgane
    [J]. NEUROPSYCHOPHARMACOLOGY, 2020, 45 (12) : 1994 - 2002
  • [27] Effects of muscarinic M1 receptor stimulation on reinforcing and neurochemical effects of cocaine in rats
    Pia Weikop
    Kathrine L. Jensen
    Morgane Thomsen
    [J]. Neuropsychopharmacology, 2020, 45 : 1994 - 2002
  • [28] 5-HT6 receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine
    Frantz, KJ
    Hansson, KJ
    Stouffer, DG
    Parsons, LH
    [J]. NEUROPHARMACOLOGY, 2002, 42 (02) : 170 - 180
  • [29] DIFFERENTIAL BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF COMPETITIVE AND NONCOMPETITIVE NMDA RECEPTOR ANTAGONISTS IN RATS
    BUBSER, M
    KESEBERG, U
    NOTZ, PK
    SCHMIDT, WJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 229 (01) : 75 - 82
  • [30] Enhanced behavioral and neurochemical response to binge cocaine in adolescent rats.
    Kuhn, CM
    Caster, J
    Walker, QD
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S135 - S135